1. Academic Validation
  2. Estrogen receptor beta selective ligands: discovery and SAR of novel heterocyclic ligands

Estrogen receptor beta selective ligands: discovery and SAR of novel heterocyclic ligands

  • Bioorg Med Chem Lett. 2005 Dec 15;15(24):5562-6. doi: 10.1016/j.bmcl.2005.08.010.
Richard Chesworth 1 Matthew D Wessel Lisa Heyden F Michael Mangano Michael Zawistoski Laura Gegnas David Galluzzo Bruce Lefker Kimberly O Cameron Jeanne Tickner Bihong Lu Tessa A Castleberry Donna N Petersen Amy Brault Pia Perry Oicheng Ng Thomas A Owen Lydia Pan Hua-Zhu Ke Thomas A Brown David D Thompson Paul DaSilva-Jardine
Affiliations

Affiliation

  • 1 Cardiovascular and Metabolic Diseases, Medicinal Chemistry, Pfizer Global Research and Development, Groton Laboratories, Eastern Point Road, Groton, CT 06340, USA. rchesworth@gmail.com
Abstract

A series of ligands with varying heterocyclic cores and substituents that display a range of selectivity's (up to >100x) for ER-beta over ER-alpha are reported.

Figures